SAN

99.62

-0.56%↓

EI

248.8

-7.03%↓

SHL.DE

46.38

-7.09%↓

ARGX

535.8

+0.3%↑

FRE

39.76

+0.86%↑

SAN

99.62

-0.56%↓

EI

248.8

-7.03%↓

SHL.DE

46.38

-7.09%↓

ARGX

535.8

+0.3%↑

FRE

39.76

+0.86%↑

SAN

99.62

-0.56%↓

EI

248.8

-7.03%↓

SHL.DE

46.38

-7.09%↓

ARGX

535.8

+0.3%↑

FRE

39.76

+0.86%↑

SAN

99.62

-0.56%↓

EI

248.8

-7.03%↓

SHL.DE

46.38

-7.09%↓

ARGX

535.8

+0.3%↑

FRE

39.76

+0.86%↑

SAN

99.62

-0.56%↓

EI

248.8

-7.03%↓

SHL.DE

46.38

-7.09%↓

ARGX

535.8

+0.3%↑

FRE

39.76

+0.86%↑

Search

Merck KGaA

Chiusa

121.85 -3.02

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

121.5

Massimo

126.6

Metriche Chiave

By Trading Economics

Entrata

-142M

667M

Vendite

152M

5.4B

P/E

Media del settore

26.27

63.778

EPS

2.2

Rendimento da dividendi

1.34

Margine di Profitto

12.311

EBITDA

85M

1.6B

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+39.46% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

1.34%

2.39%

Utili prossimi

15 mag 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

33B

98B

Apertura precedente

124.87

Chiusura precedente

121.85

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bearish Evidence

Merck KGaA Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

6 mar 2025, 06:27 UTC

Utili

Merck KGaA Forecasts Earnings, Sales Growth After In-Line Results

11 feb 2025, 07:03 UTC

Acquisizioni, Fusioni, Takeovers

Germany's Merck in Talks to Buy SpringWorks Therapeutics

10 feb 2025, 16:38 UTC

I principali Market Mover
Acquisizioni, Fusioni, Takeovers

SpringWorks Therapeutics Shares Rise on Report it May be Acquired

6 mar 2025, 11:18 UTC

Discorsi di Mercato
Utili

Impact from U.S. Tariffs Is Manageable for Merck KGaA, CEO Says -- Market Talk

6 mar 2025, 11:14 UTC

Discorsi di Mercato

Merck KGaA's Outlook Signals Greater Transparency -- Market Talk

6 mar 2025, 08:20 UTC

Discorsi di Mercato
Utili

Merck KGaA's Earnings Guidance Seems Soft Amid Semiconductor Uncertainty -- Market Talk

6 mar 2025, 06:00 UTC

Utili

Merck KGaA Expects 2025 Net Sales Between EUR21.5B and EUR22.9B

6 mar 2025, 06:00 UTC

Utili

Merck KGaA 2024 Adj EPS EUR8.63

6 mar 2025, 06:00 UTC

Utili

Merck KGaA Expects 2025 EBITDA Before One-Time Items Between EUR6.1B and EUR6.6B

6 mar 2025, 06:00 UTC

Utili

Merck KGaA 2024 EBIT EUR3.645B

6 mar 2025, 06:00 UTC

Utili

Merck KGaA 2024 After-Tax Profit EUR2.79B

6 mar 2025, 06:00 UTC

Utili

Merck KGaA 2024 Ebitda Before One-Time Items EUR6.07B

6 mar 2025, 06:00 UTC

Utili

Merck KGaA 2024 EBITDA EUR5.78B

6 mar 2025, 06:00 UTC

Utili

Merck KGaA 2024 Sales EUR21.16B

6 mar 2025, 06:00 UTC

Utili

Merck KGaA Keeps Dividend at EUR2.20

6 mar 2025, 06:00 UTC

Utili

Analysts Saw Merck KGaA 2024 Sales at EUR21.14B

6 mar 2025, 06:00 UTC

Utili

Analysts Saw Merck KGaA 2024 Ebitda Before One-Time Items at EUR6.08B

11 feb 2025, 16:45 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Merck's Potential Springworks Deal Unlikely to Move Needle on Earnings -- Market Talk

11 feb 2025, 10:54 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Germany's Merck Potential Buy of SpringWorks Therapeutics Puts Its Strategy Into Question -- Market Talk

11 feb 2025, 10:52 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

German Merck's Potential Buy of SpringWorks Therapeutics Holds Profitability Risk -- Market Talk

6 gen 2025, 13:08 UTC

Acquisizioni, Fusioni, Takeovers

Merck KGaA: Transaction closed on Dec. 23, 2024

6 gen 2025, 13:07 UTC

Acquisizioni, Fusioni, Takeovers

Merck KGaA: Didn't Disclose Financial Details

6 gen 2025, 13:06 UTC

Acquisizioni, Fusioni, Takeovers

Merck KGaA: HUB's Organoid Offering Complements Merck KGaA's Cell Culture Portfolio

6 gen 2025, 13:04 UTC

Acquisizioni, Fusioni, Takeovers

Merck KaA Acquires HUB Organoids Holding B.V. to Expand Its Next-Generation Biology Portfolio

17 dic 2024, 13:05 UTC

Acquisizioni, Fusioni, Takeovers

Merck: Deal Expected to Close By End Dec. 2024

17 dic 2024, 13:04 UTC

Acquisizioni, Fusioni, Takeovers

Merck: Terms of Deal Undisclosed

17 dic 2024, 13:04 UTC

Acquisizioni, Fusioni, Takeovers

Merck Signs Pact to Buy HUB Organoids

17 dic 2024, 13:03 UTC

Acquisizioni, Fusioni, Takeovers

Merck: Acquisition Advances Next Gen Biology Portfolio

17 dic 2024, 13:03 UTC

Acquisizioni, Fusioni, Takeovers

Merck to Buy HUB Organoids Holding

14 nov 2024, 11:15 UTC

Discorsi di Mercato

Merck KGaA's Sales Target Dragged by Muted China Outlook -- Market Talk

Confronto tra pari

Modifica del prezzo

Merck KGaA Previsione

Obiettivo di Prezzo

By TipRanks

39.46% in crescita

Previsioni per 12 mesi

Media 175.86 EUR  39.46%

Alto 190 EUR

Basso 160 EUR

Basato su 9 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Merck KGaA - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

9 ratings

7

Acquista

2

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

N/A / 126.35Supporto e resistenza

A breve termine

Strong Bearish Evidence

A termine intermedio

Weak Bullish Evidence

A lungo termine

Strong Bearish Evidence

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Merck KGaA

There is no Profile data available for MRK.BE.